| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |